Stock PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Market Closed - Nasdaq
Other stock markets
 04:00:03 2024-05-31 pm EDT 		5-day change 1st Jan Change
1.79 USD -7.73% Intraday chart for Pacific Biosciences of California, Inc. -4.28% -81.75%
May. 15 Pacific Biosciences, Ambry Genetics Selected to Sequence up to 7,000 Human Genomes MT
May. 15 Morgan Stanley Adjusts Price Target on Pacific Biosciences of California to $4 From $10, Maintains Equal-Weight Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Other Advanced Medical Equipment & Technology
-7.73%-4.28%-81.75%-85.54%-73.28% 488M
Bullish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. PACB Stock
  4. Charts Pacific Biosciences of California, Inc.
  5. Comparison Chart